trending Market Intelligence /marketintelligence/en/news-insights/trending/D_zJB2Tvku7fYH1GUWSPsQ2 content esgSubNav
In This List

Editas Medicine director resigns

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Editas Medicine director resigns

Douglas Cole resigned as director of Editas Medicine Inc., effective Dec. 21.

Cole's decision to resign did not result from any disagreement with the company on any matter relating to the company's operations, policies or practices.